Canada House Builds on Sales License with Clinic Expansion in Fredericton
14 January 2019 - 11:30PM
Canada House Wellness Group Inc. (“Canada House” or the “Company”)
(CSE:CHV) is pleased to announce the January 21st opening in
Fredericton of its eleventh medical cannabis clinic under its
wholly owned subsidiary, Canada House Clinics Inc. (“CHC”). The
clinic is located downtown in New Brunswick’s capital city at 140
King Street.
CHC is committed to helping many more Canadians improve their
physical and mental health with personalized medical cannabis
treatment plans. Each of the CHC locations across Canada
offer highly trained nurses working as Cannabinoid Therapy
Educators as well as licensed and specially trained
Prescribers. The clinics support patients through
education, specialized treatment plans, medical documents, licensed
producer registration and ongoing support.
“CHC will be opening additional clinics in 2019 in major cities
across Canada to supplement its existing network of clinics near
military bases,” said Canada House CEO Chris Churchill-Smith. “CHC
is committed to those Canadians wanting to discuss cannabinoid
therapy in a clinic setting while also providing full telemedicine
options.”
The historical placement of CHC clinics near military bases was
for the founding mission to help alleviate the suffering of
veterans struggling with their operational stress injuries.
With a broader cross-section of Canadians coming to CHC
locations for years for common to complex medical conditions,
Canada House Clinics is committed to opening additional locations
in larger urban centers while also continuing to support
veterans.
As part of improving access for more Canadians, Canada House
will also be relocating its Moncton clinic in February to a more
convenient and central location.
Canada House Wellness Group Inc.
Canada House is an experienced, integrated medical cannabis
company providing patient-specific cannabinoid therapy products and
services through its clinics and licensed producer. Canada House is
the parent company of Canada House Clinics Inc., Knalysis
Technologies and Abba Medix Corp. For more information, please
visit www.canadahouse.ca or www.sedar.com.
For further information, please contact:
Boom Capital Markets Steve Low 647-620-5101
steve@boomcapitalmarkets.com
Canada House Wellness Group Inc. Chris Churchill-Smith, CEO
514-313-0102 chris.smith@canadahouse.ca
Cautionary Statement Regarding Forward-Looking
Information. This press release contains forward-looking
statements, including statements that relate to, among other
things, the Company’s clinic, production and technology businesses,
its future plans, the Company’s markets, objectives, goals,
strategies, intentions, beliefs, expectations and estimates, and
can generally be identified by the use of words such as “may”,
“will”, “could”, “should”, “would”, “likely”, “possible”, “expect”,
“intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective”
and “continue” (or the negative thereof) and words and expressions
of similar import. Although the Company believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed on such statements.
Certain material factors or assumptions are applied in making
forward-looking statements, and actual results may differ
materially from those expressed or implied in such statements.
Material assumptions used to develop forward-looking
information in this news release include, among other things, the
regulations related to cannabis use under the Access to Cannabis
for Medical Purposes Regulations and the act respecting cannabis
and to amend the Controlled Drugs and Substances Act, the
Criminal Code and other Acts, passed by the Canadian Federal
government, making cannabis legal for recreational use by October
17, 2018; Company liquidity and capital resources, including the
availability of additional capital resources to fund its
activities; level of competition; the ability to adapt products and
services to the changing market; the ability to attract and retain
key executives; and the ability to execute strategic plans.
Additional information about material factors that could cause
actual results to differ materially from expectations and about
material factors or assumptions applied in making forward-looking
statements may be found in the Company’s most recent annual and
interim Management’s Discussion and Analysis under “Risk and
Uncertainties” as well as in other public disclosure documents
filed with Canadian securities regulatory authorities. The Company
does not undertake any obligation to update publicly or to revise
any of the forward-looking statements contained in this document,
whether as a result of new information, future events or otherwise,
except as required by law.
Neither the CSE nor its Regulation Services Provider (as that
term is defined in the policies of the CSE) accepts responsibility
for the adequacy or accuracy of this release.
Churchill Ventures Ltd (AMEX:CHV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Churchill Ventures Ltd (AMEX:CHV)
Historical Stock Chart
From Jul 2023 to Jul 2024